Xiao-fei Lv
74 Zhongshan 2 Rd
Guangzhou, 510080, China
Guangzhou, 510080, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 68 publications
Diagnostic Performance of Anti-Epstein-Barr Virus BNLF2b in Suspected Nasopharyngeal Carcinoma.
Journal: JAMA oncology
Published: March 19, 2026
[18F] Fluorodeoxyglucose positron emission tomography/computed tomography scan and liquid biopsy at 12 weeks posttreatment for surveillance of locoregionally advanced nasopharyngeal carcinoma.
Journal: European journal of nuclear medicine and molecular imaging
Published: July 03, 2025
Potential values of uEXPLORER total-body PET/CT in nasopharyngeal carcinoma: dynamic imaging and kinetic parameters.
Journal: European journal of radiology
Published: December 02, 2024
ClC-5 knockout mitigates angiotensin II-induced hypertension and endothelial dysfunction.
Journal: Life sciences
Published: September 08, 2024
Loss of Smooth Muscle Tenascin-X Inhibits Vascular Remodeling Through Increased TGF-β Signaling.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: June 27, 2024
Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trial.
Journal: The Lancet. Oncology
Published: June 18, 2024
Smooth muscle cell Piezo1 is essential for phenotypic switch and neointimal hyperplasia.
Journal: British journal of pharmacology
Published: January 20, 2024
Vascular smooth muscle-specific LRRC8A knockout ameliorates angiotensin II-induced cerebrovascular remodeling by inhibiting the WNK1/FOXO3a/MMP signaling pathway.
Journal: Acta pharmacologica Sinica
Published: November 28, 2023
Radiomic signatures associated with tumor immune heterogeneity predict survival in locally recurrent nasopharyngeal carcinoma.
Journal: Journal of the National Cancer Institute
Published: August 08, 2023
Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 08, 2023
Paclitaxel liposome, cisplatin and 5-fluorouracil-based induction chemotherapy followed by de-escalated intensity-modulated radiotherapy with concurrent cisplatin in stage IVA-IVB childhood nasopharyngeal carcinoma in endemic area: a phase II, single-arm trial.
Journal: The Lancet regional health. Western Pacific
Published: April 21, 2023
Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial.
Journal: Nature communications
Published: February 17, 2023
Last Updated: 09/26/2026